Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, August 2, 2021
[ Mon, Aug 02nd 2021
] - WOPRAI
[ Mon, Aug 02nd 2021
] - WOPRAI
[ Mon, Aug 02nd 2021
] - WOPRAI
[ Mon, Aug 02nd 2021
] - WOPRAI
[ Mon, Aug 02nd 2021
] - WOPRAI
[ Mon, Aug 02nd 2021
] - WOPRAI
[ Mon, Aug 02nd 2021
] - WOPRAI
[ Mon, Aug 02nd 2021
] - WOPRAI
[ Mon, Aug 02nd 2021
] - WOPRAI
[ Mon, Aug 02nd 2021
] - WOPRAI
[ Mon, Aug 02nd 2021
] - WOPRAI
[ Mon, Aug 02nd 2021
] - WOPRAI
[ Mon, Aug 02nd 2021
] - WOPRAI
[ Mon, Aug 02nd 2021
] - WOPRAI
[ Mon, Aug 02nd 2021
] - WOPRAI
[ Mon, Aug 02nd 2021
] - WOPRAI
[ Mon, Aug 02nd 2021
] - WOPRAI
Sun, August 1, 2021
[ Sun, Aug 01st 2021
] - WOPRAI
[ Sun, Aug 01st 2021
] - WOPRAI
[ Sun, Aug 01st 2021
] - WOPRAI
[ Sun, Aug 01st 2021
] - WOPRAI
[ Sun, Aug 01st 2021
] - WOPRAI
Fri, July 30, 2021
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
[ Fri, Jul 30th 2021
] - WOPRAI
Michael King Maintained (AGIO) at Strong Buy with Increased Target to $93 on, Jul 30th, 2021
Michael King of HC Wainwright & Co., Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Strong Buy with Increased Target from $88 to $93 on, Jul 30th, 2021.
Michael has made no other calls on AGIO in the last 4 months.
There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Danielle Brill of "Raymond James" Initiated at Hold on, Thursday, July 1st, 2021
This is the rating of the analyst that currently disagrees with Michael
- John Newman of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $65 on, Friday, April 30th, 2021
